Vaccine Manufacturing and Innovation Centre acquired by Catalent
Pennine MSK Partnership acquired by Vita Health Group
Vaccine Manufacturing and Innovation Centre Limited (VMIC), a company limited by guarantee, was developing a facility located on the highly prestigious Harwell Science and Innovation campus near Oxford. The board of VMIC and the UK government decided to divest of the part-built facility as it was no longer deemed strategic and they wanted to secure future employment for the current workforce as well as a long-term partnership with an appropriate buyer from a suitable geography. Catalent, a large US CDMO, acquiring VMIC reinforces the UK’s future vaccine manufacturing resilience and has generated a huge employment opportunity in the UK.
IPRS Group is a diversified healthcare group, a provider of case management, rehabilitation and wellbeing services to corporates and private health insurers, as well as specialist assessment capabilities (including disability assessment) to government organisations. This is the biggest deal yet completed by the acquisitive handl Group and will allow it to become a provider of a broad range of complementary services, incorporating people and technology, across different sectors.
Vita Health Group, who're backed by Archimed, have acquired Pennine MKK Partnership, who specialise in orthopedics, rheumatology and persistent pain in community settings across several sites in and around Greater Manchester. This acquisition will increase Vita Health Groups footprint in the community care space and help build on their growing NHS MSK portfolio.
IPRS Group acquired by handl Group
